Lorella Orsucci

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 364 citations · Full text

Neuro-oncology, Radiation Oncology, Lymphoid Neoplasia +12

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Meletios Α. Dimopoulos, Alessandra Tedeschi, Judith Trotman et al. · New England Journal of Medicine · 2018 · 342 citations · Full text

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

Umberto Vitolo, Annalisa Chiappella, Andrés J.M. Ferreri et al. · Journal of Clinical Oncology · 2011 · 233 citations · Full text

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · Leukemia · 2022 · 146 citations · Full text

Neuro-oncology, Lymphoid Neoplasia, Transplantation +9